A5013897032- Helicobacter pylori-related gastroenterology studies
- Pancreatic and Hepatic Oncology Research
- Diet and metabolism studies
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
- Gut microbiota and health
Nanjing Jiangning Hospital
2016-2022
Nanjing Medical University
2022
Our objective is to compare the cost-utility of icotinib and gefitinib for second-line treatment advanced non-small cell lung cancer (NSCLC) from perspective Chinese healthcare system.Model technology was applied assess data randomized clinical trials direct medical costs system. Five-year quality-adjusted life years (QALYs) incremental ratios (ICURs) were calculated. One-way probabilistic sensitivity analyses (PSA) performed.Our model suggested that median progression-free survival (PFS)...
This study aims to explore gut microbiota dysbiosis in the histological stages of gastric cancer (GC). Feces samples and clinical characteristics were collected from patients with different GC, including 15 superficial gastritis (SG), 13 atrophic (AG), 8 mucosal atypical hyperplasia (GMAH), advanced GC cases. The diversity composition among four groups determined by sequencing V4 region bacterial 16S rRNA genes. Reduced microbial alpha altered dissimilarity community structure found groups....